2023-09-12 15:49:54 ET
More on Biogen
- Seeking Alpha’s Quant Rating on Biogen
- Historical earnings data for Biogen
- Financial information for Biogen
- Biogen Inc. ( BIIB ) Morgan Stanley 21st Annual Global Healthcare Conference (Transcript)
- Stocks To Watch: Eyes On CPI, New iPhones, And Google Vs. U.S. Trial
- Biogen: Leqembi Could Boost Prospects Until Acquisition Comes Into Play
- Biogen Q2 2023 Analysis: Reata Acquisition, Financials, And Alzheimer's Prospects
- Reata Pharmaceuticals climbs as HSR waiting period for sale to Biogen expired
- Biogen in $1.5B unsecured loan facility for Reata acquisition
- RBC Capital sees Biogen stock undervaluing Leqembi prospects
- FDA approves Sandoz's biosimilar of Biogen's blockbuster MS drug Tysabri
For further details see:
Intas reportedly readying bid of up to $1B for Biogen biosimilars unit